Category
Description
Enabling regenerative medicine with off-the-shelf tissue scaffolds.
Long Description
ViVita’s patent-pending platform technology—the ViVita Process—removes the immunological barriers in animal-derived tissues, rendering them immune-compatible with human patients. Leveraging this technology, ViVita aims to generate off-the-shelf tissue and organ replacements that avoid long-term medication, repeat transplants, and associated patient deaths.
